Why the study?
Evidence-based educational resources were needed to improve understanding of key biochemical, analytical, and clinical aspects of natriuretic peptides, including BNP and NT-proBNP, with a focus on heart failure.
Design
Educational recommendations report from the IFCC C-CB
Updates NP guidance for HF care; extends integrated biochemical, analytical, and clinical recommendations for clinicians and researchers.
The IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) has directives and initiatives focused on providing evidence-based educational resources to aid and improve understanding around key analytical and clinical aspects of cardiac biomarkers used in clinical practice and the research setting. As a task force, we have previously published position statements and recommendations focused on use and analytical aspects of high-sensitivity cardiac troponin assays. The current educational document is the first from the C-CB highlighting important biochemical, analytical, and clinical aspects as they relate to the natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), with a focus on heart failure.
No takes yet. Share an insight, caveat, or question.
Kavsak et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: